arrow
S

Stefania Dispinseri

national health laboratory service
H指数:10
被引数:745

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Early Combination Antiretroviral Therapy Initiation During Primary HIV Infection Restricts HIV Reservoirs and Gut-Driven Inflammation but Fails to Rewire the Systemic Cytokine Landscape

早期在原发HIV感染期间启动联合抗逆转录病毒治疗可限制HIV储库和肠道驱动的炎症,但未能重塑系统性细胞因子景观。

2026-03-160
OA
Monitoring broadly neutralising HIV antibody concentrations using microsampling on dried blood spots in infants

使用微采样干血斑监测婴儿中广谱中和HIV抗体的浓度

2026-01-010
OA
Viral and immune profiles during the first wave of SARS-CoV-2 infection in hospitalized patients in Sardinia, Italy
2025-02-240
OAAI
Experimental medicine study with stabilised native-like HIV-1 Env immunogens drives long-term antibody responses, but lacks neutralising breadth

使用稳定类天然HIV-1 Env免疫原的实验医学研究能够驱动长期抗体应答,但缺乏广谱中和能力。

2025-02-010
OAAI
Safety and pharmacokinetics of subcutaneous administration of broadly neutralizing anti-HIV-1 monoclonal antibodies (bNAbs), given to HIV-1 exposed, uninfected neonates and infants: study protocol for a phase I trial
2024-07-201
OAAI
Case Report: Favorable outcome of allogeneic hematopoietic stem cell transplantation in SARSCoV2 positive recipient, risk-benefit balance between infection and leukemia
2023-05-235
OAAI
Seasonal Betacoronavirus Antibodies' Expansion Post-BNT161b2 Vaccination Associates with Reduced SARS-CoV-2 VoC Neutralization

季节性Betacoronavirus抗体在疫苗接种Post-BNT161b2的扩展与减少SARS-CoV-2 VoC中和有关

2022-01-097
OAAI
Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival
2021-05-11276
OAAI
Robust Neutralizing Antibodies to SARS-CoV-2 Develop and Persist in Subjects with Diabetes and COVID-19 Pneumonia
2021-01-2937
OA
Mild SARS-CoV-2 Infection After Gene Therapy in a Child With Wiskott-Aldrich Syndrome: A Case Report
2020-11-249
OAAI
Superior Efficacy of a Human Immunodeficiency Virus Vaccine Combined with Antiretroviral Prevention in Simian-Human Immunodeficiency Virus-Challenged Nonhuman Primates
2016-06-0112
OAAI
Spontaneous control of HIV-1 viremia in a subject with protective HLA-B plus HLA-C alleles and HLA-C associated single nucleotide polymorphisms
2014-12-059
OAAI
Rational design of HIV vaccine and microbicides: report of the EUROPRISE annual conference (vol 8, pg 82, 2010)
2010-09-031
OAAI
Rational design of HIV vaccine and microbicides: report of the EUROPRISE annual conference
2010-07-265
OAAI